Takeda Ventures is a private equity general partner firm headquartered in Palo Alto, CA, United States.
OrphoMed, a clinical stage biopharmaceutical company, has secured $39m in Series A from NEA, Takeda Ventures, Pappas Capital and others.
BiomX, an Israel-based microbiome therapeutics company, raised $24m in a Series A from OrbiMed, and others.
Kirsten Drejer is stepping down from its CEO position at PE-backed Symphogen and will become an independent member of the Board.
Read more news concerning Takeda Ventures
A sampling of Takeda Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?